港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

483.596

-13.124-2.64%

漲家數：10

跌家數：20

平家數：3

市盈率：- -

高：497.296

開：496.590

低：482.380

收：496.720

成交量：3,829.43萬

成交額：12.19億

市值：3,071.41億

流通市值：2,732.40億

資料載入中...

總覽新聞資訊

創勝集團醫藥－Ｂ(06628)股價上升6.667%，現價港幣$0.88

阿斯达克财经

江小涓：這個數據大家不要吃驚，未來幾年還要漲

凤凰网港股

和鉑醫藥－Ｂ(02142)股價下跌5.027%，現價港幣$12.09

阿斯达克财经

創新藥概念局部走強恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來

港股異動 | 歐康維視生物-B(01477)升逾3% 近日OT-301新藥上市註冊申請獲國家藥監局受理

康方生物(09926)出現大手賣出8.1萬股，成交價$90.0，涉資729萬

阿斯达克财经

康方生物(09926)股價下跌5.039%，現價港幣$90.45

阿斯达克财经

基石藥業－Ｂ(02616)股價下跌5.13%，現價港幣$5.64

阿斯达克财经

藥明巨諾－Ｂ(02126)股價上升5.013%，現價港幣$2.095

阿斯达克财经

中生製藥(01177.HK)TQH2722注射液新藥上市申請獲得受理

阿斯达克财经

貝康醫療-B(02170.HK)：GEMS系列玻璃化冷凍液及解凍液套裝獲國家藥監局頒發三類醫療器械註冊證

蘇州貝康醫療-B：Gems玻璃化冷凍及復甦套裝獲NMPA三類醫療器械註冊證

康為世紀(688426.SH)：艱難梭菌tpi和毒素A、毒素B基因檢測試劑盒(熒光PCR法)獲三類醫療器械註冊證

康寧傑瑞製藥-B(09966)9月15日斥資96.7萬港元回購12.2萬股

凌愈製藥高端複雜注射劑項目奠基：攻堅「製劑皇冠明珠」，「中國製造」劍指全球市場

科華生物(002022.SZ)：兩款產品獲得醫療器械註冊證

董事長兼總裁吳豫生增持同源康醫藥-B(02410.HK)40萬股每股作價約2.82港元

創新藥「一日遊」？華寶基金藥ETF、港股通創新藥ETF雙雙回調！基本面仍有支撐：數據讀出+出海邏輯持續驗證

全球首個！上海交大教授創辦，AI製藥拿下C1輪融資

勁方醫藥-B(02595)9月15日斥資129.56萬港元回購5萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1574/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":483.59592,"timestamp":1789534978515,"preClose":496.71994,"halted":0,"volume":38294256,"delay":0,"changeRate":-0.026421,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-13.124023,"latestTime":"09-16 13:02:58","open":496.59045,"high":497.2955,"low":482.37997,"amount":1218786971,"amplitude":0.030028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789546200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":3.69899,"peRate":164.598608,"turnoverRate":0.001457,"increases":10,"decrements":20,"flats":2,"marketCap":307140805856,"floatMarketCap":273239998584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":497.2955,"amplitude":0.030028,"preClose":496.71994,"low":482.37997,"pbRate":"3.69899","latestPrice":483.59592,"volume":38294256,"delay":0,"open":496.59045,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.388,"twentyDayClose":492.831,"sixtyDayClose":437.952,"secType":"PLATE","market":"HK","turnoverRate":0.001457,"peRate":164.598608,"marketCap":307140805856,"floatMarketCap":273239998584,"timestamp":1789534978515,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":10,"down":20,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667224674","title":"創勝集團醫藥－Ｂ(06628)股價上升6.667%，現價港幣$0.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2667224674","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667224674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:58","pubTimestamp":1789531080,"startTime":"0","endTime":"0","summary":"[上升股]创胜集团医药－Ｂ(06628) 股价在上午11:57比前收市价上升6.667%，现股价为港币$0.88。至目前为止，今日最高价为$0.88，而最低价为$0.78。总成交量为25.2万股，总成交金额为港币$20.738万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609161589/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609161589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","159938","BK1515","09939","06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667674545","title":"江小涓：這個數據大家不要吃驚，未來幾年還要漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667674545","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667674545?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:44","pubTimestamp":1789530285,"startTime":"0","endTime":"0","summary":"江小涓表示，我国创新药产业正迎来全球化爆发新阶段，产业规模与国际影响力持续攀升。江小涓解释，依托AI平台找到治病靶点、匹配新化合物，我国拥有了新药青苗，成果本身很好，但还只是一棵青苗，还需要把好苗对外授权进行进一步培育和商业化。江小涓进一步解释，AI会使产业链出现一些变化。江小涓说，“所以AI for Science不仅仅是我们把自己做好，还会引起全球产业链非常快速的调整，这些行业都是如此，这是一个非常大的变化。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8wSeX6t1BpL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","VTHR","AIPO","CHAT","IBBQ","BK1161","MEDX","QTOC","LNGR","AGIX","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667947","title":"和鉑醫藥－Ｂ(02142)股價下跌5.027%，現價港幣$12.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667947","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667947?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:34","pubTimestamp":1789526040,"startTime":"0","endTime":"0","summary":"[下跌股]和铂医药－Ｂ(02142) 股价在上午10:33比前收市价下跌5.027%，现股价为港币$12.09。至目前为止，今日最高价为$12.76，而最低价为$12.09。总成交量为172.9万股，总成交金额为港币$2.153千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916652/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916652/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1574","02142","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上，国金证券表示，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。诚通证券表示，2025年为创新药海外授权BD大年，2026H1我国创新药海外授权BD交易继续大幅增长，总交易金额已接近1000亿美元，国产创新药已从偶发性出海转变为系统性趋势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0348827113.USD","LNGR","LU2148510915.USD","LU1328615791.USD","LU0043850808.USD","09688","BK0060","01477","159992","LU0307460666.USD","01177","06978","LU0359201612.USD","LU1655091616.SGD","BK1574","LU1255011170.USD","BK1515","LU0456846285.SGD","LU0516422952.EUR","KURE","LU2097828557.USD","LU0327786744.USD","LU0417516902.SGD","LU1023057109.AUD","MEDX","IE00BZ08YS42.EUR","IE00B0JY6N72.USD","LU0405327148.USD","LU2039709279.SGD","LU0588546209.SGD","LU2097828805.USD","600276","LU0140636845.USD","LU0128526141.USD","02269","LU0561508036.HKD","LU2580892789.USD","LU1820825898.SGD","LU1997244956.HKD","BK0188","BK0183","LU2488822045.USD","LU1146622755.USD","LU1580142542.USD","01276","LU0348825331.USD","IBBQ","02637","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679314","title":"港股異動 | 歐康維視生物-B(01477)升逾3% 近日OT-301新藥上市註冊申請獲國家藥監局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679314","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679314?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525205,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，欧康维视生物-B涨超3%，截至发稿，涨1.78%，报5.435港元，成交额131.89万港元。消息面上，近日，欧康维视生物-B发布公告，OT-301作为降低开角型青光眼或高眼压症患者的眼内压疗法的新药上市注册申请已获中华人民共和国(中国)国家药品监督管理局药品审评中心受理，并获Mont Blanc试验及Denali试验的数据支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","VXUS","KCAI","BK1574","IPOS","01477","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667167913","title":"康方生物(09926)出現大手賣出8.1萬股，成交價$90.0，涉資729萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667167913","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667167913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525200,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午10:20出现大手卖出，成交量为8.1万，成交价为港币$90.0，涉资729万。至目前为止，股价跌5.354%，今日最高价为$94.6，而最低价为$89.95，总成交量为534.6万股，总成交金额港币$4.89亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163518/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609163518/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09926","LU0417516571.SGD","LU0348735423.USD","IE00B543WZ88.USD","BK1574","LU0540923850.HKD","LU0348766576.USD","LU1794554557.SGD","LU0634319403.HKD","LU2399975544.HKD","LU0561508036.HKD","LU0348784397.USD","LU0348825331.USD","LU1961090484.USD","LU0348767384.USD","LU2476274720.SGD","LU2476274308.USD","LU0417516902.SGD","KURE","LU2488822045.USD","LU0348827113.USD","BK1161","LU0417516738.SGD","IE00BPRC5H50.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU1720050803.USD","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679675","title":"康方生物(09926)股價下跌5.039%，現價港幣$90.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679675","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679675?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524840,"startTime":"0","endTime":"0","summary":"[下跌股]康方生物(09926) 股价在上午10:13比前收市价下跌5.039%，现股价为港币$90.45。至目前为止，今日最高价为$94.6，而最低价为$90.45。总成交量为434.8万股，总成交金额为港币$3.991亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916563/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916563/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0348735423.USD","LU1720050803.USD","LU0348825331.USD","LU0348827113.USD","BK1161","LU0348783233.USD","LU0348767384.USD","BK1574","LU0348784397.USD","LU1961090484.USD","LU0348766576.USD","LU0561508036.HKD","LU2476274308.USD","LU0417516571.SGD","09926","LU2778985437.USD","LU2476274720.SGD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2488822045.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU0634319403.HKD","LU1794554557.SGD","LU2399975544.HKD","LU0417516902.SGD","KURE","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667609679","title":"基石藥業－Ｂ(02616)股價下跌5.13%，現價港幣$5.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2667609679","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667609679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524840,"startTime":"0","endTime":"0","summary":"[下跌股]基石药业－Ｂ(02616) 股价在上午10:13比前收市价下跌5.13%，现股价为港币$5.64。至目前为止，今日最高价为$5.95，而最低价为$5.64。总成交量为228.55万股，总成交金额为港币$1.316千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916561/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260916561/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667230676","title":"藥明巨諾－Ｂ(02126)股價上升5.013%，現價港幣$2.095","url":"https://stock-news.laohu8.com/highlight/detail?id=2667230676","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667230676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:50","pubTimestamp":1789523400,"startTime":"0","endTime":"0","summary":"[上升股]药明巨诺－Ｂ(02126) 股价在上午09:49比前收市价上升5.013%，现股价为港币$2.095。至目前为止，今日最高价为$2.095，而最低价为$2.025。总成交量为25.25万股，总成交金额为港币$52.017万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260916461/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260916461/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02126","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667732986","title":"中生製藥(01177.HK)TQH2722注射液新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667732986","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667732986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 08:47","pubTimestamp":1789519620,"startTime":"0","endTime":"0","summary":"中生制药公布，附属公司正大天晴药业集团自主研发的国家1类创新药TQH2722注射液“IL-4Rα单抗”已向中国国家药品监督管理局药品审评中心递交新药上市申请并获得受理，用于外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。TQH2722是一款靶向白细胞介素4受体α的全人源单克隆抗体，有助降低2型炎症相关病理反应。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544640/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544640/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1574","01177","BK1191","BK1515","01477","BK1589","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667400546","title":"貝康醫療-B(02170.HK)：GEMS系列玻璃化冷凍液及解凍液套裝獲國家藥監局頒發三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667400546","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667400546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:46","pubTimestamp":1789479966,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09996","BK1583","BK1597","02170","BK1222","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117355886","title":"蘇州貝康醫療-B：Gems玻璃化冷凍及復甦套裝獲NMPA三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=1117355886","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117355886?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:45","pubTimestamp":1789479939,"startTime":"0","endTime":"0","summary":"苏州贝康医疗-B宣布，其Gems玻璃化冷冻及复苏套装已正式获得国家药品监督管理局颁发的三类医疗器械注册证书。这一里程碑式的进展，标志着该公司在辅助生殖技术领域的又一次重要突破。据悉，此次获批的Gems系列产品，专为胚胎和卵子的冷冻保存及解冻复苏环节精心打造。未来，贝康医疗将持续深耕辅助生殖全产业链，力求以更具创新性的产品矩阵，满足多元化的临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1574","BK1222","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644048","title":"康為世紀(688426.SH)：艱難梭菌tpi和毒素A、毒素B基因檢測試劑盒(熒光PCR法)獲三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644048","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644048?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:04","pubTimestamp":1789473869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪 发布公告，近日，公司全资子公司江苏健为诊断科技有限公司自主研发的艰难梭菌tpi和毒素A、毒素B基因检测试剂盒获得国家药品监督管理局颁发的Ⅲ类《医疗器械注册证》。该产品通过对粪便样本中tpi、tcdA及tcdB基因的同步检测，辅助临床诊断艰难梭菌感染。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","MDEV","IEIH","LNGR","688426","BK0239","HART","LGHT","PCR","MEDX","AGNG","159883","PTH","GDOC","09996","RSPH","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644517","title":"康寧傑瑞製藥-B(09966)9月15日斥資96.7萬港元回購12.2萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644517","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644517?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:44","pubTimestamp":1789472658,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年9月15日斥资96.7万港元回购12.2万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667564486","title":"凌愈製藥高端複雜注射劑項目奠基：攻堅「製劑皇冠明珠」，「中國製造」劍指全球市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2667564486","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667564486?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:34","pubTimestamp":1789472040,"startTime":"0","endTime":"0","summary":"9月15日，浙江凌愈制药有限公司高端复杂注射剂项目奠基仪式在浙江台州举行。复杂注射剂被誉为“制剂工业皇冠上最难摘的明珠”，涵盖微球、脂质体、长效缓释制剂等前沿剂型，是医药产业迈向全球价值链高端的关键突破口。凌愈制药由海正药业与圣兆药物于2025年12月合资组建。本次项目奠基，不仅是一座工厂的破土动工，更是国产高端复杂注射剂跻身全球高端制剂市场的郑重宣言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-15/doc-inirxhzq8487339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667450641","title":"科華生物(002022.SZ)：兩款產品獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667450641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667450641?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:18","pubTimestamp":1789471138,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司及公司控股子公司苏州天隆生物科技有限公司(以下简称“苏州天隆”)收到国家药品监督管理局颁发的医疗器械注册证(体外诊断试剂)。涉及药品：“沙眼衣原体核酸检测试剂盒(PCR-荧光法)”、“副流感病毒核酸检测试剂盒(荧光PCR法)”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEIH","AGNG","LNGR","159883","GDOC","BK0028","RSPH","002022","BK0239","BK1574","MEDX","BK0046","LGHT","BK1583","HART","BK1100","09996","BK0188","PTH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641986","title":"董事長兼總裁吳豫生增持同源康醫藥-B(02410.HK)40萬股 每股作價約2.82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:07","pubTimestamp":1789470429,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","BK1574","02410","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964132","title":"創新藥「一日遊」？華寶基金藥ETF、港股通創新藥ETF雙雙回調！基本面仍有支撐：數據讀出+出海邏輯持續驗證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964132","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964132?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:04","pubTimestamp":1789470240,"startTime":"0","endTime":"0","summary":"逆市大涨之后，9月15日，A+H创新药短线迎来回调，药ETF华宝、港股通创新药ETF华宝标的指数分别收跌0.8%、1.48%。创新药龙头数据读出。出海逻辑持续验证。逢跌埋伏创新药，关注两大投资工具：港股通创新药ETF华宝：紧密跟踪恒生港股通创新药精选指数，100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-15/doc-inirxhzq8476737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1574","BK4550","FDN","IBBQ","LNGR","MEDX","FLHK","159316","BK4588","159992","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667467806","title":"全球首個！上海交大教授創辦，AI製藥拿下C1輪融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2667467806","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667467806?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 18:00","pubTimestamp":1789466400,"startTime":"0","endTime":"0","summary":"今日，宇道生物宣布完成数千万美元的C1轮融资。一家专攻难成药靶点的公司宇道生物是国内最早依托“AI+物理”双轮驱动技术，系统性攻克难成药靶标药物研发的行业龙头企业之一，由AI+变构领域全球顶级科学家、上海交通大学特聘教授张健创立。技术方面，公司搭建了全球规模领先的蛋白构象调控数据库AlloMatrix，并自研拥有自主知识产权的AI+物理计算平台AlloStar。本轮融资主要用于加速AI+物理计算平台迭代和核心管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-15/doc-inirxats8585013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VTHR","01477","CHAT","ARTY","AGIX","BK1191","BK1574","QTOC","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664559","title":"勁方醫藥-B(02595)9月15日斥資129.56萬港元回購5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664559","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 17:50","pubTimestamp":1789465841,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月15日，该公司斥资129.56万港元回购5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","BK1515","159938","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":1,"totalSize":341,"code":"91000000","status":"200"}]}}